Detalles de la búsqueda
1.
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
Br J Cancer
; 130(7): 1157-1165, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38326601
2.
Optimization of decellularization methods using human small intestinal submucosa for scaffold generation in regenerative medicine.
Int J Exp Pathol
; 104(6): 313-320, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37622735
3.
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Gastric Cancer
; 26(6): 1020-1029, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37610558
4.
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.
Int J Clin Oncol
; 28(11): 1501-1510, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634209
5.
The comparison of prognoses between total and distal gastrectomy for gastric cancer in elderly patients ≥ 80 years old.
Surg Today
; 53(5): 569-577, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36418575
6.
[A Case of Stage â £c dMMR Transverse Colon Cancer with Complete Response to Combination Therapy with Immune Checkpoint Inhibitor in Stage â £B Lung Adenocarcinoma].
Gan To Kagaku Ryoho
; 50(10): 1114-1116, 2023 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-38035848
7.
[A Curatively Resected Case of Recto-Sigmoidal Cancer with Massive Bladder Invasion after Multimodal Therapy Including Chemotherapy].
Gan To Kagaku Ryoho
; 50(4): 529-531, 2023 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-37066477
8.
[A Case of Liver Metastasis of Gastric Cancer Successfully Treated with SOX plus Nivolumab].
Gan To Kagaku Ryoho
; 50(13): 1813-1815, 2023 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-38303216
9.
The prognostic significance of preoperative nutritional/inflammatory markers and clinicopathological features in resectable esophagectomy patients: possibility of nutritional intervention.
Esophagus
; 20(2): 234-245, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327058
10.
Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
Oncologist
; 27(4): 251-e304, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380725
11.
Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate, and Operative Morbidity and Mortality.
Ann Surg Oncol
; 29(2): 924-932, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480277
12.
Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study.
BMC Cancer
; 22(1): 811, 2022 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35870893
13.
Prognostic factors for elderly gastric cancer patients who underwent gastrectomy.
World J Surg Oncol
; 20(1): 10, 2022 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34996481
14.
Survival analyses of elderly gastric cancer patients with or without surgery.
Surg Today
; 52(1): 75-83, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014388
15.
[Long-Term Survival following Multidisciplinary Therapy for Unresectable Pancreatic Body Cancer].
Gan To Kagaku Ryoho
; 49(13): 1814-1816, 2022 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-36733008
16.
Prognostic factors for cytology-positive gastric cancer: a multicenter retrospective analysis.
Int J Clin Oncol
; 26(5): 858-866, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33598873
17.
[A Case of Pancreas Neuroendocrine Carcinoma Achieved Long-Term Survival by Carboplatin plus Etoposide Therapy].
Gan To Kagaku Ryoho
; 48(13): 1813-1815, 2021 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-35046339
18.
[Two Cases of Advanced Gastric Cancer with ParaâAortic Lymph Node Metastasis or Recurrence for Which Nivolumab Therapy Were Effective].
Gan To Kagaku Ryoho
; 48(4): 575-577, 2021 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-33976053
19.
A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).
Oncologist
; 25(2): 119-e208, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043772
20.
Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials.
Int J Clin Oncol
; 25(9): 1635-1643, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32494981